PTGS2 and early-onset autosomal dominant Alzheimer disease: Cox-2 inhibitor is believed to have a beneficial effect in the treatment of cognitive impairment through its role in reducing inflammation as the previous study has proved its role in diseases that associated with cognitive impairment such as Alzheimer disease (Jordan et al. 2020).